Canadian application, no grantCanada
Il-8 receptor antagonists
CA 2375683 A1 · Owner: Smithkline Beecham Corporation · Inventors: Palovich, Michael R.; Widdowson, Katherine L.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the novel use of phenyl ureas in the treatment of disease states mediated by the chemokine Interleukin-8 (IL-8).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 26, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 26, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 26, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 26, 2000
GrantedNo grant recorded
Term endedMay 26, 2020
Patent numberCA 2375683 A1
Classification (IPC)C07D513/04 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.